Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Chen, Jing ^a   Stahl, Andreas ^a,b   Krah, Nathan M ^a   Seaward, Molly R ^a   Joyal, Jean Sebastian ^a   Juan, Aimee M ^a   Hatton, Colman J ^a   Aderman, Christopher M ^a   Dennison, Roberta J ^a   Willett, Keirnan L ^a   Sapieha, Przemyslaw ^a,c   Smith, Lois E H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; AMINO ACID TRANSPORTER SLC38A5; CLAUDIN 5; MEMBRANE PROTEIN; PLASMALEMMA VESICLE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CARRIER PROTEIN; DISHEVELLED PROTEINS; EYE PROTEIN; FRIZZLED PROTEIN; FZD4 PROTEIN, MOUSE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LRP5 PROTEIN, MOUSE; NDPH PROTEIN, MOUSE; NERVE PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PLVAP PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WNT7B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; FAMILIAL EXUDATIVE VITREORETINOPATHY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; KNOCKOUT MOUSE; LRP5 GENE; MARKER GENE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MICROARRAY ANALYSIS; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PROTEIN FUNCTION; RETINA; RETINA BLOOD VESSEL; RETINA DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE DISTRIBUTION; UPREGULATION; WILD TYPE; ANIMAL; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE MUTANT; VITREORETINOPATHY; WNT SIGNALING PATHWAY;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; EYE PROTEINS; FRIZZLED RECEPTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS; RETINA; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITREORETINOPATHY, PROLIFERATIVE; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84855838132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030203     Document Type: Article

References (51)

1. Toomes C, Downey L, (1993) Familial Exudative Vitreoretinopathy, Autosomal Dominant. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet] Seattle (WA): University of Washington, Seattle; 2005 Mar 21 [updated 2011 Sep 22].
2. Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, et al. (2010) The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 51: 2813-2826.
3. Chen J, Smith LE, (2007) Retinopathy of prematurity. Angiogenesis 10: 133-140.
4. Shastry BS, (2009) Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Experiment Ophthalmol 37: 884-890.
5. Dickinson JL, Sale MM, Passmore A, FitzGerald LM, Wheatley CM, et al. (2006) Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Experiment Ophthalmol 34: 682-688.
6. Berger W, (1998) Molecular dissection of Norrie disease. Acta Anat (Basel) 162: 95-100.
7. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
8. Moon RT, (2005) Wnt/beta-catenin pathway. Sci STKE 2005: cm1.
9. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
10. Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF, (2004) Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am J Hum Genet 75: 878-884.
11. Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, et al. (2005) Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum Mutat 26: 104-112.
12. Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, et al. (2004) Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet 74: 721-730.
13. Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, et al. (2002) Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 32: 326-330.
14. Chen ZY, Battinelli EM, Fielder A, Bundey S, Sims K, et al. (1993) A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 5: 180-183.
15. Shastry BS, Hejtmancik JF, Trese MT, (1997) Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat 9: 396-401.
16. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, et al. (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116: 883-895.
17. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314.
18. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
19. Xia CH, Yablonka-Reuveni Z, Gong X, (2010) LRP5 is required for vascular development in deeper layers of the retina. PLoS One 5: e11676.
20. Xia CH, Liu H, Cheung D, Wang M, Cheng C, et al. (2008) A model for familial exudative vitreoretinopathy caused by LPR5 mutations. Hum Mol Genet 17: 1605-1612.
21. Ye X, Wang Y, Cahill H, Yu M, Badea TC, et al. (2009) Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139: 285-298.
22. Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, et al. (2011) Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 124: 1871-1881.
23. Luhmann UF, Lin J, Acar N, Lammel S, Feil S, et al. (2005) Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci 46: 3372-3382.
24. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, et al. (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322: 1247-1250.
25. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, et al. (2009) Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 106: 641-646.
26. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, et al. (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437: 417-421.
27. Liu C, Nathans J, (2008) An essential role for frizzled 5 in mammalian ocular development. Development 135: 3567-3576.
28. Zhou CJ, Wang YZ, Yamagami T, Zhao T, Song L, et al. (2010) Generation of Lrp6 conditional gene-targeting mouse line for modeling and dissecting multiple birth defects/congenital anomalies. Dev Dyn 239: 318-326.
29. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
30. Campbell M, Nguyen AT, Kiang AS, Tam LC, Gobbo OL, et al. (2009) An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci U S A 106: 17817-17822.
31. Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, et al. (2008) Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC Neurosci 9: 29.
32. Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, et al. (2009) The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 114: 478-484.
33. Schafer NF, Luhmann UF, Feil S, Berger W, (2009) Differential gene expression in Ndph-knockout mice in retinal development. Invest Ophthalmol Vis Sci 50: 906-916.
34. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, et al. (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183: 409-417.
35. Umapathy NS, Dun Y, Martin PM, Duplantier JN, Roon P, et al. (2008) Expression and function of system N glutamine transporters (SN1/SN2 or SNAT3/SNAT5) in retinal ganglion cells. Invest Ophthalmol Vis Sci 49: 5151-5160.
36. Umapathy NS, Li W, Mysona BA, Smith SB, Ganapathy V, (2005) Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Muller cells. Invest Ophthalmol Vis Sci 46: 3980-3987.
37. Harada T, Harada C, Watanabe M, Inoue Y, Sakagawa T, et al. (1998) Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci U S A 95: 4663-4666.
38. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, et al. (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653-660.
39. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, et al. (2008) The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 14: 1067-1076.
40. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, et al. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15: 4738-4747.
41. Chan-Ling T, Gock B, Stone J, (1995) The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36: 1201-1214.
42. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, et al. (2010) von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 137: 1563-1571.
43. Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, et al. (2010) O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12: 1007-1013.
44. Chen Y, Hu Y, Zhou T, Zhou KK, Mott R, et al. (2009) Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175: 2676-2685.
45. Zhang B, Zhou KK, Ma JX, (2010) Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes 59: 1809-1816.
46. Zhou T, Zhou KK, Lee K, Gao G, Lyons TJ, et al. (2010) The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia 54: 459-468.
47. Zhou T, Hu Y, Chen Y, Zhou KK, Zhang B, et al. (2010) The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci 51: 4371-4379.
48. Chen J, Connor KM, Aderman CM, Smith LE, (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118: 526-533.
49. Stahl A, Connor KM, Sapieha P, Willett KL, Krah NM, et al. (2009) Computer-aided quantification of retinal neovascularization. Angiogenesis 12: 297-301.
50. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, et al. (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4: 1565-1573.
51. Zheng Q, Wang XJ, (2008) GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 36: W358-363.